Gandara DR - Search Results

1

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.

Rittmeyer A, Barlesi F, Waterkamp D, Park K, Ciardiello F, von Pawel J, Gadgeel SM, Hida T, Kowalski DM, Dols MC, Cortinovis DL, Leach J, Polikoff J, Barrios C, Kabbinavar F, Frontera OA, De Marinis F, Turna H, Lee JS, Ballinger M, Kowanetz M, He P, Chen DS, Sandler A, Gandara DR; OAK Study Group. Rittmeyer A, et al. Among authors: gandara dr. Lancet. 2017 Jan 21;389(10066):255-265. doi: 10.1016/S0140-6736(16)32517-X. Epub 2016 Dec 13. Lancet. 2017. PMID: 27979383 Free PMC article. Clinical Trial.

2

Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomas.

Valone FH, Gandara DR, Deisseroth AB, Perez EA, Rayner A, Aronson FR, Luce J, Paradise C. Valone FH, et al. Among authors: gandara dr. J Immunother (1991). 1991 Jun;10(3):207-13. doi: 10.1097/00002371-199106000-00007. J Immunother (1991). 1991. PMID: 1651106 Clinical Trial.

3

High-dose cisplatin and mitomycin C in advanced non-small cell lung cancer: a phase II study of the Northern California Oncology Group.

Gandara DR, Perez EA, Wold H, Caggiano V, Malec M, Ahn DK, Meyers F, Carlson RW. Gandara DR, et al. Cancer Chemother Pharmacol. 1990;27(3):243-7. doi: 10.1007/BF00685721. Cancer Chemother Pharmacol. 1990. PMID: 2176134 Clinical Trial.

4

Cisplatin dose intensity in non-small cell lung cancer: phase II results of a day 1 and day 8 high-dose regimen.

Gandara DR, Wold H, Perez EA, Deisseroth AB, Doroshow J, Meyers F, McWhirter K, Hannigan J, De Gregorio MW. Gandara DR, et al. J Natl Cancer Inst. 1989 May 10;81(10):790-4. doi: 10.1093/jnci/81.10.790. J Natl Cancer Inst. 1989. PMID: 2541260

5

Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer.

Perez EA, Gandara DR. Perez EA, et al. Among authors: gandara dr. Semin Oncol. 1994 Jun;21(3 Suppl 4):2-5. Semin Oncol. 1994. PMID: 8209273 Review.

6

Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group.

Gandara DR, Crowley J, Livingston RB, Perez EA, Taylor CW, Weiss G, Neefe JR, Hutchins LF, Roach RW, Grunberg SM, et al. Gandara DR, et al. J Clin Oncol. 1993 May;11(5):873-8. doi: 10.1200/JCO.1993.11.5.873. J Clin Oncol. 1993. PMID: 8387576 Clinical Trial.

7

Promising new agents in the treatment of non-small cell lung cancer.

Edelman MJ, Gandara DR. Edelman MJ, et al. Among authors: gandara dr. Cancer Chemother Pharmacol. 1996;37(5):385-93. doi: 10.1007/s002800050402. Cancer Chemother Pharmacol. 1996. PMID: 8599859 Review.

8

Concurrent carboplatin, etoposide and thoracic radiation for poor-risk stage III non-small-cell lung carcinoma: a pilot study.

Lau DH, Ryu JK, Gandara DR, Rosenthal SA. Lau DH, et al. Among authors: gandara dr. Int J Radiat Oncol Biol Phys. 1997 Apr 1;38(1):157-61. doi: 10.1016/s0360-3016(97)00249-6. Int J Radiat Oncol Biol Phys. 1997. PMID: 9212018

9

Twice-weekly paclitaxel and radiation for stage III non-small cell lung cancer.

Lau DH, Ryu JK, Gandara DR, Morgan R, Doroshow J, Wilder R, Leigh B. Lau DH, et al. Among authors: gandara dr. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-106-S12-109. Semin Oncol. 1997. PMID: 9331132 Clinical Trial.

10

Chemoradiotherapy for poor-risk stage III non-small cell lung cancer.

Lau DH, Ryu JK, Gandara DR. Lau DH, et al. Among authors: gandara dr. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-110-S12-112. Semin Oncol. 1997. PMID: 9331133 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters